Fox Run Management L.L.C. purchased a new stake in shares of Colgate-Palmolive Company (NYSE:CL – Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 21,682 shares of the company’s stock, valued at approximately $1,733,000.
Several other institutional investors and hedge funds also recently bought and sold shares of CL. Brighton Jones LLC boosted its stake in shares of Colgate-Palmolive by 4.4% during the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock worth $962,000 after purchasing an additional 450 shares during the period. Woodline Partners LP lifted its stake in Colgate-Palmolive by 76.3% in the first quarter. Woodline Partners LP now owns 46,361 shares of the company’s stock worth $4,344,000 after purchasing an additional 20,062 shares during the last quarter. Schnieders Capital Management LLC. boosted its position in shares of Colgate-Palmolive by 2.0% during the second quarter. Schnieders Capital Management LLC. now owns 12,494 shares of the company’s stock valued at $1,136,000 after buying an additional 245 shares during the period. Resonant Capital Advisors LLC bought a new position in shares of Colgate-Palmolive during the second quarter valued at approximately $233,000. Finally, Envestnet Asset Management Inc. raised its holdings in shares of Colgate-Palmolive by 0.4% in the second quarter. Envestnet Asset Management Inc. now owns 678,352 shares of the company’s stock worth $61,662,000 after buying an additional 2,768 shares during the period. 80.41% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several equities analysts have commented on CL shares. Bank of America upped their price objective on Colgate-Palmolive from $90.00 to $100.00 and gave the company a “buy” rating in a research report on Monday, February 2nd. Jefferies Financial Group upped their price target on shares of Colgate-Palmolive from $85.00 to $91.00 and gave the stock a “hold” rating in a report on Monday, February 2nd. Wells Fargo & Company lifted their price objective on shares of Colgate-Palmolive from $86.00 to $94.00 and gave the company an “equal weight” rating in a report on Sunday, February 1st. The Goldman Sachs Group reaffirmed a “buy” rating and set a $100.00 target price on shares of Colgate-Palmolive in a research report on Friday. Finally, Morgan Stanley lifted their price target on shares of Colgate-Palmolive from $87.00 to $100.00 and gave the company an “overweight” rating in a research note on Monday, February 2nd. Eleven equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, Colgate-Palmolive has an average rating of “Moderate Buy” and an average price target of $94.75.
Insider Buying and Selling
In related news, CFO Stanley J. Sutula III sold 97,843 shares of the firm’s stock in a transaction dated Wednesday, February 4th. The stock was sold at an average price of $94.27, for a total transaction of $9,223,659.61. Following the sale, the chief financial officer owned 55,310 shares of the company’s stock, valued at $5,214,073.70. This trade represents a 63.89% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider John Hazlin sold 20,989 shares of Colgate-Palmolive stock in a transaction dated Tuesday, February 10th. The shares were sold at an average price of $94.25, for a total value of $1,978,213.25. Following the completion of the transaction, the insider owned 17,645 shares in the company, valued at $1,663,041.25. This trade represents a 54.33% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 184,683 shares of company stock valued at $17,486,693. Company insiders own 0.41% of the company’s stock.
Colgate-Palmolive Trading Up 1.0%
NYSE:CL opened at $98.08 on Wednesday. The firm has a 50-day simple moving average of $86.35 and a 200-day simple moving average of $82.43. Colgate-Palmolive Company has a one year low of $74.54 and a one year high of $100.18. The firm has a market cap of $79.06 billion, a P/E ratio of 37.43, a P/E/G ratio of 4.38 and a beta of 0.29. The company has a debt-to-equity ratio of 5.90, a quick ratio of 0.27 and a current ratio of 0.42.
Colgate-Palmolive (NYSE:CL – Get Free Report) last issued its quarterly earnings data on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.91 by $0.04. The company had revenue of $5.23 billion for the quarter, compared to analyst estimates of $5.13 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. Colgate-Palmolive’s revenue was up 5.8% compared to the same quarter last year. During the same period last year, the company posted $0.91 earnings per share. Equities analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.
Colgate-Palmolive Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, February 13th. Stockholders of record on Wednesday, January 21st were given a $0.52 dividend. This represents a $2.08 annualized dividend and a dividend yield of 2.1%. The ex-dividend date of this dividend was Wednesday, January 21st. Colgate-Palmolive’s payout ratio is presently 79.39%.
Colgate-Palmolive News Roundup
Here are the key news stories impacting Colgate-Palmolive this week:
- Positive Sentiment: Morgan Stanley maintained a Buy and set a $100 price target, citing reaccelerating growth from pet nutrition, emerging markets and innovation — a direct fundamental endorsement for CL’s stock. Colgate-Palmolive: Reaccelerating Growth — TipRanks
- Positive Sentiment: Colgate‑Palmolive (India) announced a large public-health tie‑up with the Haryana government to deliver oral‑health education to millions of students — supportive for brand, distribution and long‑term top‑line in a key emerging market. Colgate-Palmolive, Haryana Government Tie-Up — TipRanks
- Positive Sentiment: Industry report projects faster cosmetics market growth through 2033 and lists Colgate among major players — a secular tailwind for segments tied to personal care and innovation. Global Cosmetics Market Competitive Landscape Report — Yahoo
- Neutral Sentiment: Analyst commentary compares Colgate to peers (including P&G and Kroger) on growth, margins and valuation — useful for investors assessing relative upside but not an immediate directional catalyst. Analysts Offer Insights on Consumer Goods Companies — Globe and Mail
- Neutral Sentiment: Technical note: coverage flagged rising relative strength for CL but said it remains below a key threshold — suggests improving momentum but not yet a clear breakout signal. Colgate‑Palmolive shows rising relative strength — MSN
- Negative Sentiment: Unusually large put‑option buying (about 18,150 puts, ~256% above average) signals elevated bearish hedging or speculation — a short‑term pressure or volatility signal for the stock.
- Negative Sentiment: Governance/DEI dispute: Colgate said it will ask investors to vote against a proposal to remove DEI criteria for board selection, drawing media attention and a conservative shareholder challenge — potential reputational/governance noise that could concern some institutional investors. Colgate‑Palmolive plans to defend DEI criteria — Reuters via Yahoo
About Colgate-Palmolive
Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.
The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.
Further Reading
- Five stocks we like better than Colgate-Palmolive
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- This makes me furious
- What a Former CIA Agent Knows About the Coming Collapse
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
